Delivery Order SPE2DB22D3301-SPE2DB23FZ0CD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,580.30 to AmerisourceBergen Drug Corp for the supply of Cyclophosphamide 1 GM vials, with an ultimate completion date of September 5, 2025. This is a firm fixed-price, non-set-aside contract with performance at the contractor's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is...
- The Defense Logistics Agency awarded a $749 delivery order to Amerisourcebergen Drug Corporation for 500 mg vials of the pharmaceutical cyclophosphamide. The order was placed under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services in support of DLA and other Department of Defense requirements. Performance will take place in Conshohocken, Pennsylvania over a three-day period from June 30 to July 3, 2023. The firm fixed price order was...
- The Defense Logistics Agency Troop Support Medical awarded a $14,793.60 firm fixed price delivery order to Amerisourcebergen Drug Corp for 1,000 vials of the chemotherapy drug cyclophosphamide. Place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in late August 2023. As a major distributor of pharmaceuticals and medical supplies, Amerisourcebergen will fulfill this order to supply critical chemotherapy medications in support of the Defense...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $1,144.10 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply cyclophosphamide 1 gm/5 ml vials. The order was awarded on November 30, 2023 under the company's existing indefinite delivery contract with no set-aside designation specified. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania with completion by December...
- The Defense Logistics Agency awarded a delivery order valued at $1,120.74 to AmerisourceBergen Drug Corp for the supply of Cyclophosphamide 500 mg vials. The contract, awarded on August 8, 2025, with an ultimate completion date of August 11, 2025, operates under firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $1,849.20 firm fixed price delivery order contract to Amerisourcebergen Drug Corp for cyclophosphamide 500 mg vials. The place of performance is Conshohocken, Pennsylvania. The contract completion date is March 23, 2023. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is a division of Amerisourcebergen Corporation, which will serve as the prime contractor supplying the cyclophosphamide vials to the Defense Logistics Agency in...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $77,013.02 firm fixed price contract is for the supply of 4,565,682,849 vials of the chemotherapy drug cyclophosphamide. The award is part of a larger Indefinite Delivery Contract valued at up to $999,999,999 through December 2025 that provides a comprehensive range of medical commodities to support military treatment programs and...
- The Defense Logistics Agency Troop Support Medical awarded a $7,558.31 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 capsules of the pharmaceutical cyclophosphamide. Place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania distribution facility. The order is to be filled on July 19th and completed by July 20th, 2023. Amerisourcebergen Corporation, which does business as Amerisourcebergen, is the parent company of Amerisourcebergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Cyclophosphamide 50 mg capsules (100 count) valued at $1,942.93. This is a firm fixed-price delivery order with a completion deadline of September 9, 2025, and no set-aside designation was utilized. The work will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen Drug...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $12,465.36 firm fixed-price contract is for the delivery of 2 gram vials of the drug Cyclophosphamide, with a completion date of November 15, 2024. The award is associated with Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB23FZ0CDDelivery Order
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $804.85 delivery order contract by the Defense Logistics Agency to provide 500 mg vials of the chemotherapy drug cyclophosphamide. Performance will take place in Conshohocken, Pennsylvania over a one-day period from June 26-27, 2023. The firm fixed price contract was awarded under the DLA's Prime Vendor program, which establishes indefinite-delivery/indefinite-quantity contracts with commercial distributors to facilitate delivery of pharmaceuticals and other medical supplies to military treatment facilities worldwide. No subcontractors or set-aside designations were identified. The award will enable DLA to maintain critical stock levels of cyclophosphamide, an alkylating agent commonly used to treat various cancers, in support of the Military Health System.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $805 | 6/26/23 |